← All indications
Leishmaniasis, Mucocutaneous
A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
Drugs by status
Approved for this indication (1)
Phase 3 trials (3)
Phase 2 trials (1)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)